Searched for
AUROBINDO PHARMA BUYBACK
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...- Another buyback offer coming soon! This time it's from Bajaj AutoBajaj Auto has announced that its board will consider a share buyback proposal on May 6, 2026, signalling plans to return surplus cash to s...
- Aurobindo Pharma's Rs 800 cr buyback closes this week: Should you tender shares?Aurobindo Pharma has initiated a share buyback program valued at Rs 800 crore, set to remain open until April 29. The company aims to reacq...
- Stocks in news: SBI Life, Trent, Tata Investment, HCL Tech, Suzlon EnergyIn today's trade, shares of SBI Life, Trent, Tata Investment, HCL Tech, Suzlon Energy among others will be in focus due to various news dev...
- Aurobindo Pharma announces schedule, record date for its Rs 800 crore share buybackAurobindo Pharma has announced an Rs 800 crore share buyback via the tender route, offering Rs 1,475 per share. The buyback opens April 23 ...
- Buyback alert! Last date to buy Aurobindo Pharma shares for Rs 800-crore share buyback. Check detailsAurobindo Pharma has announced an ₹800-crore buyback at ₹1,475 per share, with April 17, 2026 set as the record date—meaning investors must...
- Share buybacks this month: Wipro, Aurobindo Pharma, 2 other stocks to watch out forFour companies—Wipro, Cyient, Windlas Biotech, and Aurobindo Pharma—are set to announce or act on share buybacks this month, with Aurobindo...
- Aurobindo Pharma share buyback, Muthoot Fin dividend, 2 other corporate actions next weekAurobindo Pharma’s share buyback and Muthoot Finance’s dividend announcement headline a set of four key corporate actions lined up for the ...
- Pharma, Auto, and IT: Pankaj Pandey shares sectoral insights amid global challengesPankaj Pandey shares insights on Indian sectors facing US tariffs. He sees limited impact on pharma growth but potential benefits for Jubil...
- Aurobindo Pharma approves Rs 800 crore share buyback. Check record date, other key detailsAurobindo Pharma is launching its first share buyback in two years, offering to repurchase over 54 lakh shares at Rs 1,475 each. This tende...
- Raining Buybacks: 6 companies announce buybacks post Budget. More to follow?Companies such as Welspun Living and Aurobindo Pharma have already announced share buybacks, while AIA Engineering, Savita Oil Technologies...
- Aurobindo Pharma approves Rs 750 crore buyback at 6.4% premiumAurobindo Pharma announced on Thursday that its board has approved a buyback of 51.37 lakh shares at Rs 1,460 per share, marking a 6.4% pre...
- Aurobindo Pharma board to consider buyback of shares, stock jumps 5%Aurobindo Pharma board meeting on July 18, 2024, to discuss share buyback. Stocks hit Rs 1,394, a record. First-ever buyback. Shares soared...
- Corporate Radar: LIC Q4 results, JSW Steel's dividend, Tilaknagar's referential issue & moreLIC, Sun Pharma, IRCTC, Jindal Steel & Power, Delhivery, Jubilant FoodWorks and Aurobindo Pharma are among the companies which will announc...
- Kunal Bothra’s 2 top trading ideas for MondayNifty could come back to the 11,400 zone next week, says Bothra
- Hang on to cement stocks as long-term investment: Yogesh Mehta, Motilal Oswal SecuritiesWe strongly believe in terms of valuations, we would like to have Aurobindo Pharma rather than Sun Pharma at this point in time
- Promoter holdings remain same as India pharma battles rough seasIn two cases - Dr Reddy's and Strides Shasun -promoter stakes have increased marginally.
- Cos line up to buy back outstanding FCCBsApart from reducing equity overhang, buyback will help cash-rich firms retire their debts. Gainers: BSE ( A, B ) | NSE | Losers: BSE ( A, B...
- Cos line up to buy back outstanding FCCBsIncreasing disparity between the bond conversion price and the market price has resulted in a few companies expressing their desire to buy ...
- Heard on the StreetRumours of a buyback have been propping up the share price of Aurobindo Pharma over the past one week
Load More
